http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_57bebee8e77ae22f63623c82fdb06a6b
Outgoing Links
Predicate | Object |
---|---|
family-name | Brown |
name | Nathan Brown |
given-name | Nathan |
organization-name | Krebs Institute for Biomolecular Research, Department of Information Studies, University of Sheffield, Western Bank, Sheffield, S10 2TN, U.K. BenevolentAI, 40 Churchway, London, NW1 1LW, UK Cancer Research UK Cancer Therapeutics Unit Division of Cancer Therapeutics The Institute of Cancer Research London UK Cancer Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, United Kingdom Cancer Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutics, The Institute of Cancer Research, London SM2 5NG, United Kingdom Avantium Technologies B.V., P.O. Box 2915, 1000 CX, Amsterdam, The Netherlands, and Computer-Chemie-Centrum and the Institute for Organic Chemistry, University of Erlangen-Nürnberg, Nägelsbachstrasse 25, D-91052, Erlangen, Germany BenevolentAI, London, United Kingdom. BenevolentAI, 4-8 Maple Street, W1T 5HD London, U.K. Dept. of Electrical Eng. and Computer Sc., Case Western Reserve University, USA. Department of Genetics and Genome Biology, University of Leicester, Leicester, United Kingdom. Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock Novartis Institutes for BioMedical Research, Basel, CH-4002, Switzerland, and The Krebs Institute for Biomolecular Research and Department of Information Studies, University of Sheffield, Western Bank, Sheffield S10 2TN, United Kingdom Division of Cancer Therapeutics The Institute of Cancer Research London SM2 5NG UK Cancer Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutics, The Institute of Cancer Research, London, SM2 5NG, UK BenevolentAI 40 Churchway NW1 1LW London United Kingdom Office of Environment & Energy, Federal Aviation Administration, Washington, DC 20591; Emergency and Trauma Centre, Royal Brisbane and Women’s Hospital, Brisbane; Faculty of Medicine, University of Queensland, Queensland Cancer Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey, SM2 5NG, United Kingdom Cancer Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutics, The Institute of Cancer Research, London, SM2 5NG, U.K. Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, U.K. Emergency and Trauma Centre Royal Brisbane and Women's Hospital Brisbane Australia; Faculty of Medicine University of Queensland Brisbane Australia Division of Cancer Therapeutics, Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, United Kingdom Department of Mechanical Engineering, Clemson University, 218 South Palmetto Building, Clemson, SC 29631 Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland. nathan.brown@novartis.com Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland Cancer Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey, SM2 5NG, U.K. Emergency and Trauma Centre Royal Brisbane and Women's Hospital Brisbane Queensland Australia; Faculty of Medicine The University of Queensland Brisbane Queensland Australia |
Incoming Links
Total number of triples: 120.